About Diatherix

A unique laboratory providing accurate and actionable results in one day for infectious diseases and antibiotic resistance genes utilizing innovative molecular technologies, including proprietary TEM-PCR™.

Eurofins Diatherix distinctions:
- Delivers one-day results
- Identifies bacteria regardless of recent antibiotic use
- Offers simplicity of single-sample collection
- Identifies difficult-to-culture pathogens
- Yields a high level of sensitivity and specificity

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Location
601 Genome Way, Suite 2100, Huntsville, Alabama 35806, US
description icon
Founded
2008
description icon
Keywords
Diagnostics, Infectious Disease, Gastrointestinal, Wounds, Molecular, Respiratory Infection, Stds, Tem-Pcr, Covid-19 Testing, Skin And Soft Tissue

Diatherix Alternatives

Industry
Biotechnology
Industry
biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about Diatherix

Who is the CEO of Diatherix?

Dennis Grimaud is the CEO of Diatherix.

Who are the decision makers in Diatherix?

The decision makers in Diatherix are Bernard Klemchak, Brent K, Dennis Grimaud, etc. Click to Find Diatherix decision makers emails.

What types of infectious diseases does Eurofins Diatherix test for?

Eurofins Diatherix specializes in diagnostics for a wide range of infectious diseases, including gastrointestinal infections, respiratory infections, sexually transmitted diseases (STDs), and skin and soft tissue infections. Our proprietary TEM-PCR™ technology allows us to accurately detect pathogens quickly, providing actionable results within one day.

How does the TEM-PCR™ technology work?

TEM-PCR™ (Target Enrichment Multiplex Polymerase Chain Reaction) is an innovative molecular technology developed by Eurofins Diatherix that enhances the detection of infectious agents. It allows for the simultaneous amplification and detection of multiple pathogens from a single sample, significantly increasing sensitivity and specificity. This means we can provide rapid and accurate results, which are crucial for effective patient management.

What industries does Eurofins Diatherix serve?

Eurofins Diatherix serves a variety of industries, including healthcare facilities, laboratories, and public health organizations. Our services are particularly beneficial for hospitals, urgent care centers, and clinics that require rapid diagnostic testing for infectious diseases. We also support research institutions and pharmaceutical companies in their efforts to understand and combat infectious diseases and antibiotic resistance.

How quickly can I expect results from Eurofins Diatherix?

Eurofins Diatherix prides itself on providing accurate and actionable results within one day. Our advanced molecular technologies, including TEM-PCR™, enable us to process samples efficiently, ensuring that healthcare providers receive timely information to guide patient care and treatment decisions.

What types of samples does Eurofins Diatherix accept for testing?

We accept a variety of sample types for testing, including swabs from wounds, respiratory specimens (such as nasal swabs), stool samples for gastrointestinal testing, and other biological specimens as needed. Our laboratory is equipped to handle diverse sample types to ensure comprehensive testing for infectious diseases.

Is Eurofins Diatherix involved in COVID-19 testing?

Yes, Eurofins Diatherix offers COVID-19 testing as part of our commitment to public health. We utilize our advanced molecular testing capabilities to provide accurate and rapid results for COVID-19, helping to support healthcare providers and communities in managing the pandemic effectively.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more